184 related articles for article (PubMed ID: 24224933)
1. XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks.
Zaretzki J; Matlock M; Swamidass SJ
J Chem Inf Model; 2013 Dec; 53(12):3373-83. PubMed ID: 24224933
[TBL] [Abstract][Full Text] [Related]
2. XenoSite server: a web-available site of metabolism prediction tool.
Matlock MK; Hughes TB; Swamidass SJ
Bioinformatics; 2015 Apr; 31(7):1136-7. PubMed ID: 25411327
[TBL] [Abstract][Full Text] [Related]
3. DR-predictor: incorporating flexible docking with specialized electronic reactivity and machine learning techniques to predict CYP-mediated sites of metabolism.
Huang TW; Zaretzki J; Bergeron C; Bennett KP; Breneman CM
J Chem Inf Model; 2013 Dec; 53(12):3352-66. PubMed ID: 24261543
[TBL] [Abstract][Full Text] [Related]
4. Extending P450 site-of-metabolism models with region-resolution data.
Zaretzki JM; Browning MR; Hughes TB; Swamidass SJ
Bioinformatics; 2015 Jun; 31(12):1966-73. PubMed ID: 25697821
[TBL] [Abstract][Full Text] [Related]
5. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
6. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
Dong D; Wu B
Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
[TBL] [Abstract][Full Text] [Related]
7. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
[TBL] [Abstract][Full Text] [Related]
8. Predicting the binding modes and sites of metabolism of xenobiotics.
Mukherjee G; Lal Gupta P; Jayaram B
Mol Biosyst; 2015 Jul; 11(7):1914-24. PubMed ID: 25913019
[TBL] [Abstract][Full Text] [Related]
9. A pragmatic approach using first-principle methods to address site of metabolism with implications for reactive metabolite formation.
Hsiao YW; Petersson C; Svensson MA; Norinder U
J Chem Inf Model; 2012 Mar; 52(3):686-95. PubMed ID: 22299574
[TBL] [Abstract][Full Text] [Related]
10. Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule.
Mishra NK; Agarwal S; Raghava GP
BMC Pharmacol; 2010 Jul; 10():8. PubMed ID: 20637097
[TBL] [Abstract][Full Text] [Related]
11. Molecular Docking Supplements an In vitro Determination of the Leading CYP Isoform for Arylpiperazine Derivatives.
Ulenberg S; Bączek T; Zieliñska J; Belka M; Król M; Herold F
Comb Chem High Throughput Screen; 2019; 22(6):370-378. PubMed ID: 31284855
[TBL] [Abstract][Full Text] [Related]
12. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
Crivori P; Poggesi I
Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065
[TBL] [Abstract][Full Text] [Related]
13. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
Lewis DF; Ito Y
Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
[TBL] [Abstract][Full Text] [Related]
14. Prediction of amino acid residues participated in substrate recognition by cytochrome P450 subfamilies with broad substrate specificity.
Zharkova MS; Sobolev BN; Yu Oparina N; Veselovsky AV; Archakov AI
J Mol Recognit; 2013 Feb; 26(2):86-91. PubMed ID: 23334916
[TBL] [Abstract][Full Text] [Related]
15. QNA-Based Prediction of Sites of Metabolism.
Tarasova O; Rudik A; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
Molecules; 2017 Dec; 22(12):. PubMed ID: 29194399
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
17. Combining structure- and ligand-based approaches to improve site of metabolism prediction in CYP2C9 substrates.
Kingsley LJ; Wilson GL; Essex ME; Lill MA
Pharm Res; 2015 Mar; 32(3):986-1001. PubMed ID: 25208877
[TBL] [Abstract][Full Text] [Related]
18. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
Yu X; Cojocaru V; Wade RC
Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
[TBL] [Abstract][Full Text] [Related]
19. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers.
Cheng F; Yu Y; Shen J; Yang L; Li W; Liu G; Lee PW; Tang Y
J Chem Inf Model; 2011 May; 51(5):996-1011. PubMed ID: 21491913
[TBL] [Abstract][Full Text] [Related]
20. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
Liu R; Liu J; Tawa G; Wallqvist A
J Chem Inf Model; 2012 Jun; 52(6):1698-712. PubMed ID: 22631565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
